Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V Villani
Grp94-Specific Monoclonal Antibody to Counteract BRAF Inhibitor Resistance in BRAFV600E Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas
Oncotarget
Oncology
Inhibition of YAP Function Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Stem Cells
Oncotarget
Oncology
809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma
iScience
Multidisciplinary
BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Current Cancer Drug Targets
Cancer Research
Drug Discovery
Oncology
Pharmacology
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma
BMC Cancer
Cancer Research
Oncology
Genetics
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma
Cancers
Cancer Research
Oncology
Why Do We Need a New BRAF-MEK Inhibitor Combination in Melanoma?
Oncology in Clinical Practice
Oncology